Do GLP-1RAs and SGLT-2is reduce cardiovascular events in women with type 2 diabetes? A systematic review and meta-analysis


This review found that GLP-1RAs significantly reduce the incidence of MACE in women with type 2 diabetes who either have increased CV risk or established CVD.

Mishriky BM, Okunrintemi V, Jain S, et al. Diabetes Metab 2020; epub ahead of press.